Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Complex PCI in Octogenarian

The octogenarian population has already reached 137 million and continues to grow. It is estimated to triple by 2050. 

La estrategia invasiva en pacientes frágiles es segura

This increase represents a big challenge, seeing as these patients are often more fragile, present more complex coronary artery disease and multiple comorbidities. This generally requires two or more procedures and more experience both from operators and the whole health team. 

2,657 octogenarian patients were randomized, 1,387 received complex percutaneous coronary intervention (C PCI).

Primary end point was a composite of all-cause mortality, myocardial infarction (MI) or target vessel revascularization (TVR) (MACE) at 12 months.

Mean patient age was 84, with 36% diabetic and no significant differences in kidney function. Those receiving complex PCI were more often women, smoker, hypertensive, with dyslipidemia, prior MI, prior PCI, prior CABS, atrial fibrillation and lower ejection fraction. 

Read also: High Gradients After Valve-in-Valve.

The most frequent clinical presentation was stable chronic angina, followed by unstable angina, non-ST elevation acute MI (NTEMI), ST elevation MI (STEMI), and, less frequently, silent ischemia. 

Most procedures were femoral (84%). Patients with C PCI commonly presented left main lesions, multivessel disease, lesions to the anterior descending, calcified lesions, bifurcations, longer lesions, more stents, longer stents and the need for ventricular assistance, as well as higher SYNTAX score (20.8 vs. 10.7, p<0.001).

Read also: Glycemic Control and Coronary Stent Failure.

Primary end point resulted higher in patients undergoing C PCI (16.6% vs. 11.1%, p<0.001), as well as MI incidence (4.1% vs. 1.5%, p=0.002) and TVR (8.9% vs. 4.4%, p<0.001), with no differences in all-cause mortality. Also these patients presented a higher incidence of TLR and major bleeding with no differences in post discharge stroke or major bleeding incidence. 

Conclusion

Octogenarian undergoing complex PCI are associated to higher risk of major adverse cardiovascular events (MACE) at one year, because of higher MI and TVF rate, as well as higher incidenc of major bleeding, with no difference in all-cause mortality vs. pateints undergoing non-complex PCI. We should implement strategies to reduce complications in octogenarian patients undergoing complex PCI. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians. 

Reference: Alessandro Spirito, et al. Catheter Cardiovasc Interv. 2024;103:1079–1087.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...